• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于全基因组测序的种系分类、多位点序列分型及中国南方阴沟肠杆菌复合体的抗菌药物耐药机制分析。

Whole-Genome Sequencing-Based Species Classification, Multilocus Sequence Typing, and Antimicrobial Resistance Mechanism Analysis of the Enterobacter cloacae Complex in Southern China.

机构信息

School of Medicine, Lishui University, Lishui, Zhejiang, China.

School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.

出版信息

Microbiol Spectr. 2022 Dec 21;10(6):e0216022. doi: 10.1128/spectrum.02160-22. Epub 2022 Nov 9.

DOI:10.1128/spectrum.02160-22
PMID:36350178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9769718/
Abstract

Members of the Enterobacter cloacae complex (ECC) are important opportunistic nosocomial pathogens that are associated with a great variety of infections. Due to limited data on the genome-based classification of species and investigation of resistance mechanisms, in this work, we collected 172 clinical ECC isolates between 2019 and 2020 from three hospitals in Zhejiang, China and performed a retrospective whole-genome sequencing to analyze their population structure and drug resistance mechanisms. Of the 172 ECC isolates, 160 belonged to 9 classified species, and 12 belonged to unclassified species based on ANI analysis. Most isolates belonged to E. hormaechei (45.14%) followed by E. kobei (13.71%), which contained 126 STs, including 62 novel STs, as determined by multilocus sequence typing (MLST) analysis. Pan-genome analysis of the two ECC species showed that they have an "open" tendency, which indicated that their Pan-genome increased considerably with the addition of new genomes. A total of 80 resistance genes associated with 11 antimicrobial agent categories were identified in the genomes of all the isolates. The most prevailing resistance genes (12/29, 41.38%) were related to β-lactams followed by aminoglycosides. A total of 247 β-lactamase genes were identified, of which the genes were the most dominant (145/247, 58.70%), followed by the genes (21/247, 8.50%). The inherent ACT type β-lactamase genes differed among different species. and were only present in E. asburiae, while , , and exclusively appeared in E. kobei, E. ludwigii, and E. mori. Among the six carbapenemase-encoding genes (, , , , , and ) identified, two ( and ) were identified in an ST78 E. hormaechei isolate. Comparative genomic analysis of the carbapenemase gene-related sequences was performed, and the corresponding genetic structure of these resistance genes was analyzed. Genome-wide molecular characterization of the ECC population and resistance mechanism would offer valuable insights into the effective management of ECC infection in clinical settings. The presence and emergence of multiple species/subspecies of ECC have led to diversity and complications at the taxonomic level, which impedes our further understanding of the epidemiology and clinical significance of species/subspecies of ECC. Accurate identification of ECC species is extremely important. Also, it is of great importance to study the carbapenem-resistant genes in ECC and to further understand the mechanism of horizontal transfer of the resistance genes by analyzing the surrounding environment around the genes. The occurrence of ECC carrying two MBL genes also indicates that the selection pressure of bacteria is further increased, suggesting that we need to pay special attention to the emergence of such bacteria in the clinic.

摘要

肠杆菌科复合体(ECC)成员是重要的机会性病原体,与各种感染有关。由于物种基于基因组分类和耐药机制调查的数据有限,在这项工作中,我们收集了 2019 年至 2020 年间来自中国浙江的三家医院的 172 株临床 ECC 分离株,并进行了回顾性全基因组测序,以分析其种群结构和耐药机制。在 172 株 ECC 分离株中,160 株属于 9 种已分类的种,12 株属于未分类的种,基于 ANI 分析。大多数分离株属于 E. hormaechei(45.14%),其次是 E. kobei(13.71%),它们包含 126 个 STs,其中包括 62 个新 STs,这是通过多位点序列分型(MLST)分析确定的。两种 ECC 物种的泛基因组分析表明,它们具有“开放”的趋势,这表明它们的泛基因组随着新基因组的加入而大大增加。在所有分离株的基因组中总共鉴定出与 11 种抗菌剂类别相关的 80 个耐药基因。最流行的耐药基因(12/29,41.38%)与β-内酰胺类有关,其次是氨基糖苷类。总共鉴定出 247 个β-内酰胺酶基因,其中 基因最为占主导地位(145/247,58.70%),其次是 基因(21/247,8.50%)。不同物种之间的固有 ACT 型β-内酰胺酶基因不同。和 仅存在于 E. asburiae 中,而 、 、 和 仅存在于 E. kobei、E. ludwigii 和 E. mori 中。在鉴定的 6 个碳青霉烯酶编码基因(、、、、和 )中,两种(和 )存在于 ST78 E. hormaechei 分离株中。对碳青霉烯酶基因相关序列的比较基因组分析,分析了这些耐药基因的相应遗传结构。对 ECC 群体和耐药机制的全基因组分子特征进行研究,将为有效管理临床 ECC 感染提供有价值的见解。ECC 多种种/亚种的存在和出现导致了分类水平的多样性和复杂性,这阻碍了我们进一步了解 ECC 种/亚种的流行病学和临床意义。准确识别 ECC 物种非常重要。此外,研究 ECC 中的碳青霉烯类耐药基因,并通过分析基因周围的环境进一步了解耐药基因的水平转移机制,也具有重要意义。携带两种 MBL 基因的 ECC 的出现也表明细菌的选择压力进一步增加,这表明我们需要特别注意临床中此类细菌的出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e65/9769718/dafc47e0c520/spectrum.02160-22-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e65/9769718/193e9a35bfaa/spectrum.02160-22-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e65/9769718/4b4f2034a53a/spectrum.02160-22-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e65/9769718/873df6ba5ed5/spectrum.02160-22-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e65/9769718/dafc47e0c520/spectrum.02160-22-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e65/9769718/193e9a35bfaa/spectrum.02160-22-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e65/9769718/4b4f2034a53a/spectrum.02160-22-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e65/9769718/873df6ba5ed5/spectrum.02160-22-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e65/9769718/dafc47e0c520/spectrum.02160-22-f004.jpg

相似文献

1
Whole-Genome Sequencing-Based Species Classification, Multilocus Sequence Typing, and Antimicrobial Resistance Mechanism Analysis of the Enterobacter cloacae Complex in Southern China.基于全基因组测序的种系分类、多位点序列分型及中国南方阴沟肠杆菌复合体的抗菌药物耐药机制分析。
Microbiol Spectr. 2022 Dec 21;10(6):e0216022. doi: 10.1128/spectrum.02160-22. Epub 2022 Nov 9.
2
Whole genome sequence-based molecular characterization of blood isolates of carbapenem-resistant complex from ICU patients in Kolkata, India, during 2017-2022: emergence of phylogenetically heterogeneous subsp. .2017 年至 2022 年期间,印度加尔各答 ICU 患者血源耐碳青霉烯肠杆菌科细菌的全基因组序列分子特征:种系异质性亚群的出现。
Microbiol Spectr. 2024 Apr 2;12(4):e0352923. doi: 10.1128/spectrum.03529-23. Epub 2024 Feb 22.
3
Institutional outbreak involving multiple clades of IMP-producing Enterobacter cloacae complex sequence type 78 at a cancer center in Tokyo, Japan.日本东京一家癌症中心发生涉及多个 IMP 生产肠杆菌科 cloacae 复合序列类型 78 群的多克隆爆发。
BMC Infect Dis. 2021 Mar 22;21(1):289. doi: 10.1186/s12879-021-05952-9.
4
Characterization of the population structure, drug resistance mechanisms and plasmids of the community-associated Enterobacter cloacae complex in China.中国社区获得性阴沟肠杆菌复合体的种群结构、耐药机制和质粒特征。
J Antimicrob Chemother. 2018 Jan 1;73(1):66-76. doi: 10.1093/jac/dkx361.
5
Molecular characterization of metallo-β-lactamase- producing carbapenem-resistant Enterobacter cloacae complex isolated in Heilongjiang Province of China.中国黑龙江省产金属β-内酰胺酶碳青霉烯类耐药阴沟肠杆菌复合体的分子特征。
BMC Infect Dis. 2020 Jan 31;20(1):94. doi: 10.1186/s12879-020-4768-7.
6
Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms.产碳青霉烯酶肠杆菌属的全基因组分析:系统发育、种群结构和耐药机制的新见解
mBio. 2016 Dec 13;7(6):e02093-16. doi: 10.1128/mBio.02093-16.
7
High prevalence of clonally related ST182 NDM-1-producing Enterobacter cloacae complex clinical isolates in Greece.希腊高产 NDM-1 型碳青霉烯酶肠杆菌科细菌 ST182 克隆相关的阴沟肠杆菌复合体临床分离株。
Int J Antimicrob Agents. 2023 Jul;62(1):106837. doi: 10.1016/j.ijantimicag.2023.106837. Epub 2023 May 6.
8
Whole Genome-Based Characterization of Multidrug Resistant Enterobacter and Klebsiella aerogenes Isolates from Lebanon.黎巴嫩多药耐药肠杆菌和产气克雷伯菌分离株的全基因组特征分析。
Microbiol Spectr. 2023 Feb 14;11(1):e0291722. doi: 10.1128/spectrum.02917-22. Epub 2023 Jan 18.
9
Detection of clinically relevant carbapenemase encoding genes in carbapenem-resistant Enterobacter cloacae complex and Klebsiella pneumoniae isolated from farmed freshwater fish.从养殖淡水鱼中分离的耐碳青霉烯肠杆菌科和肺炎克雷伯菌中临床相关碳青霉烯酶编码基因的检测。
J Appl Microbiol. 2023 Oct 4;134(10). doi: 10.1093/jambio/lxad212.
10
Molecular Characterization of Class 1 Integrons and Carbapenem-Resistant Genes in Enterobacter cloacae Complex Isolates.阴沟肠杆菌复合体分离株中 I 类整合子和碳青霉烯类耐药基因的分子特征
Curr Microbiol. 2024 Apr 24;81(6):158. doi: 10.1007/s00284-024-03679-9.

引用本文的文献

1
Molecular epidemiology and β-lactam resistance mechanisms of complex isolates obtained from bloodstream infections, Kyoto, Japan.日本京都血流感染分离出的复杂菌株的分子流行病学及β-内酰胺耐药机制
Microbiol Spectr. 2025 Apr;13(4):e0248524. doi: 10.1128/spectrum.02485-24. Epub 2025 Mar 10.
2
Genomic analysis of Enterobacter cloacae complex from Southern Thailand reveals insights into multidrug resistance genotypes and genetic diversity.来自泰国南部的阴沟肠杆菌复合体的基因组分析揭示了对多药耐药基因型和遗传多样性的见解。
Sci Rep. 2025 Feb 7;15(1):4670. doi: 10.1038/s41598-024-81595-5.
3
Exploring nagZ as a virulence biomarker and treatment target in Enterobacter cloacae.
探索nagZ作为阴沟肠杆菌毒力生物标志物和治疗靶点的作用。
BMC Microbiol. 2025 Jan 9;25(1):10. doi: 10.1186/s12866-024-03718-2.
4
First documentation of a clinical multidrug-resistant Enterobacter chuandaensis ST2493 isolate co-harboring bla and two bla bearing plasmids.首次报道临床多重耐药肠杆菌属楚达氏菌 ST2493 分离株同时携带 bla 和两个 bla 基因的质粒。
Sci Rep. 2024 Nov 5;14(1):26817. doi: 10.1038/s41598-024-78163-2.
5
Genomic Analysis of Species Isolated from Patients in United States Hospitals.对从美国医院患者中分离出的物种进行的基因组分析。
Antibiotics (Basel). 2024 Sep 10;13(9):865. doi: 10.3390/antibiotics13090865.
6
Genomic Study of High-Risk Clones of Collected from Tertiary Hospitals in the United Arab Emirates.从阿拉伯联合酋长国三级医院收集的高危克隆的基因组研究。
Antibiotics (Basel). 2024 Jun 26;13(7):592. doi: 10.3390/antibiotics13070592.
7
Some virulence genes are associated with antibiotic susceptibility in Enterobacter cloacae complex.某些毒力基因与阴沟肠杆菌复合体中的抗生素敏感性相关。
BMC Infect Dis. 2024 Jul 19;24(1):711. doi: 10.1186/s12879-024-09608-2.
8
Clinical Characteristics, Prognosis and Treatment of Bloodstream Infections with Complex in a Chinese Tertiary Hospital: A Retrospective Study.中国一家三级医院血流感染合并 [具体内容缺失] 的临床特征、预后及治疗:一项回顾性研究
Infect Drug Resist. 2024 May 9;17:1811-1825. doi: 10.2147/IDR.S460744. eCollection 2024.
9
Regional dissemination of NDM-1 producing ST1740, with a subset of strains co-producing VIM-4 or IMP-13, France, 2019 to 2022.2019 年至 2022 年期间,法国出现了携带 NDM-1 的 ST1740 型菌株的区域性传播,其中一部分菌株还同时产生 VIM-4 或 IMP-13。
Euro Surveill. 2024 Mar;29(11). doi: 10.2807/1560-7917.ES.2024.29.11.2300521.
10
Characterization of an NDM-1-Producing Isolate from China.一株来自中国的产NDM-1菌株的特性分析。
Infect Drug Resist. 2024 Jan 6;17:61-67. doi: 10.2147/IDR.S435771. eCollection 2024.